Natural terpenoids as a promising source for modulation of GABAergic system and treatment of neurological diseases

Pharmacological Reports

Volumn 68, Issue 4, 2016, Pages 671-679

  Manayi, Azadeh ^a   Nabavi, Seyed Mohammad ^b   Daglia, Maria ^c   Jafari, Samineh ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF PAVIA   (Italy)

^d ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anxiety; Convulsion; GABA; Terpenoids

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; BILOBALIDE; DITERPENE; GLUTAMATE DECARBOXYLASE; NATURAL PRODUCT; SESQUITERPENE DERIVATIVE; TERPENOID DERIVATIVE; TRITERPENE DERIVATIVE; 4 AMINOBUTYRIC ACID RECEPTOR; BIOLOGICAL PRODUCT; TERPENE;

ANTICONVULSANT ACTIVITY; ANXIETY DISORDER; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; CONVULSION; DRUG MECHANISM; DRUG RECEPTOR BINDING; GABAERGIC SYSTEM; HUMAN; INSOMNIA; NERVE CELL EXCITABILITY; NEUROLOGIC DISEASE; NEUROMODULATION; NONHUMAN; PAIN; REVIEW; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; NERVOUS SYSTEM DISEASES;

ANIMALS; BIOLOGICAL PRODUCTS; GABAERGIC NEURONS; HUMANS; MOLECULAR STRUCTURE; NERVOUS SYSTEM DISEASES; RECEPTORS, GABA; TERPENES;

EID: 84964344545     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2016.03.014     Document Type: Review

References (73)

1. S. Braat, and R.F. Kooy The GABAA receptor as a therapeutic target for neurodevelopmental disorders Neuron 86 2015 1119 1130
2. K.E. McCarson, and S. Enna GABA pharmacology: the search for analgesics Neurochem Res 39 2014 1948 1963
3. 2 GABAA receptors Neurochem Int 60 2012 543 554
4. J. Malin Abdullah, and J. Zhang The GABA a receptor subunits heterologously expressed in Xenopus oocytes J Med Chem 13 2013 744 748
5. A.V. Kalueff, and D.J. Nutt Role of GABA in anxiety and depression J Depress Anxiety 24 2007 495 517
6. J. Egebjerg, A. Schousboe, and P. Krogsgaard-Larsen Glutamate and GABA receptors and transporters: structure, function and pharmacology 2001 CRC Press
7. P.D. Harvey, and C.R. Bowie Cognitive enhancement in schizophrenia: pharmacological and cognitive remediation approaches Psychiatr Clin N Am 35 2012 683 698
8. R.A. Rissman, and W.C. Mobley Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer's disease J Neurochem 117 2011 613 622
9. M.E. Gibbs, and G.A. Johnston Opposing roles for GABAA and GABAC receptors in short-term memory formation in young chicks Neuroscience 131 2005 567 576
10. F. Fernandez, W. Morishita, E. Zuniga, J. Nguyen, M. Blank, R.C. Malenka, and et al. Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome Nat Neurosci 10 2007 411 413
11. G. Johnston, M. Chebib, R. Duke, S. Fernandez, J. Hanrahan, T. Hinton, and et al. Herbal products and GABA receptors Encycl Neurosci 4 2009 1095 1101
12. W.C. Evans Trease and Evans' pharmacognosy 2009 Elsevier Health Sciences
13. A. Manayi Anticancer terpenoids S Saeidnia, New approaches to natural anticancer drugs 2015 Springer International Publishing
14. 2L GABA(A) receptors Biochem Pharmacol 69 2005 1101 1111
15. L.J. Quintans-Júnior, A.G. Guimarães, B.E. Araújo, G.F. Oliveira, M.T. Santana, F.V. Moreira, and et al. Carvacrol (-)-borneol and citral reduce convulsant activity in rodents Afr J Biotechnol 9 2013 6566 6572
16. A. Guimaraes, L. Scotti, M. Scotti, F. Mendonça Júnior, N. Melo, R. Alves, and et al. Carvacrol reduces cancer pain by GABAergic system FASEB J 2015 29
17. A.G. Guimaraes, L. Scotti, M.T. Scotti, F.J. Mendonca Junior, N.S. Melo, R.S. Alves, and et al. Evidence for the involvement of descending pain-inhibitory mechanisms in the attenuation of cancer pain by carvacrol aided through a docking study Life Sci 116 2014 8 15
18. F.H. Melo, E.T. Venancio, D.P. de Sousa, M.M. de Franca Fonteles, S.M. de Vasconcelos, G.S. Viana, and et al. Anxiolytic-like effect of carvacrol (5-isopropyl-2-methylphenol) in mice: involvement with GABAergic transmission Fundam Clin Pharmacol 24 2010 437 443
19. G.N. Reiner, D.O. Labuckas, and D.A. Garcia Lipophilicity of some GABAergic phenols and related compounds determined by HPLC and partition coefficients in different systems J Pharm Biomed Anal 49 2009 686 691
20. A.P. Serafim, and L.F. Felicio Dopaminergic modulation of grooming behavior in virgin and pregnant rats Braz J Med Biol Res 34 2001 1465 1470
21. L.F. Pires, L.M. Costa, O.A. Silva, A.A. de Almeida, G.S. Cerqueira, D.P. de Sousa, and et al. Anxiolytic-like effects of carvacryl acetate, a derivative of carvacrol, in mice Pharmacol Biochem Behav 112 2013 42 48
22. D.P. de Sousa, J.C.R. Gonçalves, L. Quintans-Júnior, J.S. Cruz, D.A.M. Araújo, and R.N. de Almeida Study of anticonvulsant effect of citronellol, a monoterpene alcohol, in rodents Neurosci Lett 401 2006 231 235
23. A. Manayi, S. Saeidnia, A.R. Gohari, and M. Abdollahi Methods for the discovery of new anti-aging products - targeted approaches Expert Opin Drug Discov 9 2014 383 405
24. E. Galati, N. Miceli, M. Galluzzo, M. Taviano, and O. Tzakou Neuropharmacological effects of epinepetalactone from Nepeta sibthorpii behavioral and anticonvulsant activity Pharm Biol 42 2004 391 395
25. B. Rajeswara Rao, P. Kaul, K. Syamasundar, and S. Ramesh Comparative composition of decanted and recovered essential oils of Eucalyptus citriodora hook Flavour Fragr J 18 2003 133 135
26. S.-Y. Paik, K.-H. Koh, S.-M. Beak, S.-H. Paek, and J.-A. Kim The essential oils from Zanthoxylum schinifolium pericarp induce apoptosis of HepG2 human hepatoma cells through increased production of reactive oxygen species Biol Pharm Bull 28 2005 802 807
27. M.I.G. Silva, M.R. de Aquino Neto, P.F.T. Neto, B.A. Moura, J.F. do Amaral, D.P. de Sousa, and et al. Central nervous system activity of acute administration of isopulegol in mice Pharmacol Biochem Behav 88 2007 141 147
28. D.P.D. Sousa, E. Raphael, U. Brocksom, and T.J. Brocksom Sedative effect of monoterpene alcohols in mice: a preliminary screening Z Naturforsch C 62 2007 563 566
29. M.I.G. Silva, M.A.G. Silva, M.R. de Aquino Neto, B.A. Moura, H.L. de Sousa, E.P.H. de Lavor, and et al. Effects of isopulegol on pentylenetetrazol-induced convulsions in mice: possible involvement of GABAergic system and antioxidant activity Fitoterapia 80 2009 506 513
30. A. Oliveira, J. Almeida, R. Freitas, V. Nascimento, L. Aguiar, H. Júnior, and et al. Effects of levetiracetam in lipid peroxidation level, nitrite-nitrate formation and antioxidant enzymatic activity in mice brain after pilocarpine-induced seizures Cell Mol Neurobiol 27 2007 395 406
31. W. Zhou, M. Yoshioka, and H. Yokogoshi Sub-chronic effects of s-limonene on brain neurotransmitter levels and behavior of rats J Nutr Sci Vitaminol 55 2009 367 373
32. S. Fukumoto, A. Morishita, K. Furutachi, T. Terashima, T. Nakayama, and H. Yokogoshi Effect of flavour components in lemon essential oil on physical or psychological stress Stress Health 24 2008 3 12
33. X.B. Zhang, P. Jiang, N. Gong, X.L. Hu, D. Fei, Z.Q. Xiong, and et al. A-type GABA receptor as a central target of TRPM8 agonist menthol PLoS ONE 3 2008 e3386
34. E.E. Watt, B.A. Betts, F.O. Kotey, D.J. Humbert, T.N. Griffith, E.W. Kelly, and et al. Menthol shares general anesthetic activity and sites of action on the GABA(A) receptor with the intravenous agent, propofol Eur J Pharmacol 590 2008 120 126
35. D. Bai, G. Zhu, P. Pennefather, M.F. Jackson, J.F. MacDonald, and B.A. Orser Distinct functional and pharmacological properties of tonic and quantal inhibitory postsynaptic currents mediated by gamma-aminobutyric acid(a) receptors in hippocampal neurons Mol Pharmacol 59 2001 814 824
36. N.A. Corvalan, J.A. Zygadlo, and D.A. Garcia Stereo-selective activity of menthol on GABA(A) receptor Chirality 21 2009 525 530
37. M.M. Czyzewska, and J.W. Mozrzymas Monoterpene alpha-thujone exerts a differential inhibitory action on GABA(A) receptors implicated in phasic and tonic GABAergic inhibition Eur J Pharmacol 702 2013 38 43
38. M. Szczot, M.M. Czyzewska, G. Appendino, and J.W. Mozrzymas Modulation of GABAergic synaptic currents and current responses by α-thujone and dihydroumbellulone J Nat Prod 75 2012 622 629
39. E.M. Rivera, M.P. Cid, P. Zunino, G. Baiardi, and N.A. Salvatierra Central alpha- and beta-thujone: similar anxiogenic-like effects and differential modulation on GABAA receptors in neonatal chicks Brain Res 1555 2014 28 35
40. M. Chebib, J.R. Hanrahan, K.N. Mewett, R.K. Duke, and G.A.R. Johnston Ionotropic GABA receptors as therapeutic targets for memory and sleep disorders Annu Rep Med Chem 2004 13 23
41. D.A. Garcia, I. Vendrell, M. Galofre, and C. Sunol GABA released from cultured cortical neurons influences the modulation of t-[(35)S]butylbicyclophosphorothionate binding at the GABAA receptor effects of thymol Eur J Pharmacol 600 2008 26 31
42. D.A. Garcia, J. Bujons, C. Vale, and C. Sunol Allosteric positive interaction of thymol with the GABAA receptor in primary cultures of mouse cortical neurons Neuropharmacology 50 2006 25 35
43. D.A. Parker, V. Marino, and J. Ong Pharmacological actions of thymol and an analogue at GABAB autoreceptors Clin Exp Pharmacol Physiol 41 2014 623 627
44. H. Hosseinzadeh, and S. Parvardeh Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice Phytomedicine 11 2004 56 64
45. A.A. Al-Majed, F.A. Al-Omar, and M.N. Nagi Neuroprotective effects of thymoquinone against transient forebrain ischemia in the rat hippocampus Eur J Pharmacol 543 2006 40 47
46. J. Akhondian, H. Kianifar, M. Raoofziaee, A. Moayedpour, M.B. Toosi, and M. Khajedaluee The effect of thymoquinone on intractable pediatric seizures (pilot study) Epilepsy Res 93 2011 39 43
47. I. Ullah, H. Badshah, M.I. Naseer, H.Y. Lee, and M.O. Kim Thymoquinone and vitamin c attenuates pentylenetetrazole-induced seizures via activation of GABAB1 receptor in adult rats cortex and hippocampus Neuromol Med 17 2015 35 46
48. A.R. Korshoej, M.M. Holm, K. Jensen, and J.D.C. Lambert Kinetic analysis of evoked IPSCs discloses mechanism of antagonism of synaptic GABAA receptors by picrotoxin Br J Pharmacol 159 2010 636 649
49. A. Sedelnikova, B.E. Erkkila, H. Harris, S.O. Zakharkin, and D.S. Weiss Stoichiometry of a pore mutation that abolishes picrotoxin-mediated antagonism of the GABAA receptor J Physiol 577 2006 569 577
50. T.S. Carpenter, E.Y. Lau, and F.C. Lightstone Identification of a possible secondary picrotoxin-binding site on the GABAA receptor Chem Res Toxicol 26 2013 1444 1454
51. Y. Yoshiike, T. Kimura, S. Yamashita, H. Furudate, T. Mizoroki, M. Murayama, and et al. GABA(A) receptor-mediated acceleration of aging-associated memory decline in APP/PS1 mice and its pharmacological treatment by picrotoxin PLoS ONE 3 2008 e3029
52. G. Trauner, S. Khom, I. Baburin, B. Benedek, S. Hering, and B. Kopp Modulation of GABAA receptors by valerian extracts is related to the content of valerenic acid Planta Med 74 2008 19 24
53. S. Khom, I. Baburin, E. Timin, A. Hohaus, G. Trauner, B. Kopp, and et al. Valerenic acid potentiates and inhibits GABAA receptors: molecular mechanism and subunit specificity Neuropharmacology 53 2007 178 187
54. D. Benke, A. Barberis, S. Kopp, K.-H. Altmann, M. Schubiger, K.E. Vogt, and et al. GABAA receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts Neuropharmacology 56 2009 174 181
55. S. Khom, B. Strommer, J. Ramharter, T. Schwarz, C. Schwarzer, T. Erker, and et al. Valerenic acid derivatives as novel subunit-selective GABAA receptor ligands - in vitro and in vivo characterization Br J Pharmacol 161 2010 65 78
56. K. Sasaki, S. Hatta, K. Wada, H. Ohshika, and M. Haga Bilobalide prevents reduction of γ-aminobutyric acid levels and glutamic acid decarboxylase activity induced by 4-o-methylpyridoxine in mouse hippocampus Life Sci 67 2000 709 715
57. S.H. Huang, R.K. Duke, M. Chebib, K. Sasaki, K. Wada, and G.A.R. Johnston Bilobalide, a sesquiterpene trilactone from Ginkgo biloba, is an antagonist at recombinant α1β2γ2l GABAA receptors Eur J Pharmacol 464 2003 1 8
58. C. Kiewert, V. Kumar, O. Hildmann, M. Rueda, J. Hartmann, R.S. Naik, and et al. Role of GABAergic antagonism in the neuroprotective effects of bilobalide Brain Res 1128 2007 70 78
59. J. Singhuber, I. Baburin, H. Kählig, E. Urban, B. Kopp, and S. Hering GABAA receptor modulators from Chinese herbal medicines traditionally applied against insomnia and anxiety Phytomedicine 19 2012 334 340
60. L. Ivic, T.T.J. Sands, N. Fishkin, K. Nakanishi, A.R. Kriegstein, and K. Strømgaard Terpene trilactones from Ginkgo biloba are antagonists of cortical glycine and GABAA receptors J Biol Chem 278 2003 49279 49285
61. S.H. Huang, R.K. Duke, M. Chebib, K. Sasaki, K. Wada, and G.A.R. Johnston Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant α1β2γ2l GABAA receptors Eur J Pharmacol 494 2004 131 138
62. A. Schramm, S.N. Ebrahimi, M. Raith, J. Zaugg, D.C. Rueda, S. Hering, and et al. Phytochemical profiling of Curcuma kwangsiensis rhizome extract, and identification of labdane diterpenoids as positive GABAA receptor modulators Phytochemistry 96 2013 318 329
63. E.A. Mitchell, M.B. Herd, B.G. Gunn, J.J. Lambert, and D. Belelli Neurosteroid modulation of GABAA receptors: molecular determinants and significance in health and disease Neurochem Int 52 2008 588 595
64. J.J. Lambert, M.A. Cooper, R.D.J. Simmons, C.J. Weir, and D. Belelli Neurosteroids: endogenous allosteric modulators of GABAA receptors Psychoneuroendocrinology 34 Suppl. 1 2009 S48 S58
65. C. Marx, J. Lee, M. Subramaniam, A. Rapisarda, D.T. Bautista, E. Chan, and et al. Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia Psychopharmacology 231 2014 3647 3662
66. R.W. Irwin, and R.D. Brinton Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise Prog Neurobiol 113 2014 40 55
67. C. Patte-Mensah, L. Meyer, O. Taleb, and A.G. Mensah-Nyagan Potential role of allopregnanolone for a safe and effective therapy of neuropathic pain Prog Neurobiol 113 2014 70 78
68. R. Muceniece, K. Saleniece, J. Rumaks, L. Krigere, Z. Dzirkale, R. Mezhapuke, and et al. Betulin binds to γ-aminobutyric acid receptors and exerts anticonvulsant action in mice Pharmacol Biochem Behav 90 2008 712 716
69. C.Y.-C. Chen Chemoinformatics and pharmacoinformatics approach for exploring the GABA-A agonist from Chinese herb suanzaoren J Taiwan Inst Chem Eng 40 2009 36 47
70. R.N. de Almeida, D.P. de Sousa, F.F. de Farias Nóbrega, F. de Sousa Claudino, D.A.M. Araújo, J.R. Leite, and et al. Anticonvulsant effect of a natural compound α, β-epoxy-carvone and its action on the nerve excitability Neurosci Lett 443 2008 51 55
71. A.C. Hall, C.M. Turcotte, B.A. Betts, W.Y. Yeung, A.S. Agyeman, and L.A. Burk Modulation of human GABAA and glycine receptor currents by menthol and related monoterpenoids Eur J Pharmacol 506 2004 9 16
72. A. Kessler, H. Sahin-Nadeem, S.C. Lummis, I. Weigel, M. Pischetsrieder, A. Buettner, and et al. GABA(A) receptor modulation by terpenoids from sideritis extracts Mol Nutr Food Res 58 2014 851 862
73. R. McKernan, T. Rosahl, D. Reynolds, C. Sur, K. Wafford, J. Atack, and et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype Nat Neurosci 3 2000 587 592